ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
The impact of the COVID-19 pandemic on breast cancer survivorship: a scoping review.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe COVID-19 pandemic has affected how cancer care is delivered globally. This scoping review aimed to evaluate the impact of COVID-19 on breast cancer survivors (BCS), specifically regarding their quality of life (QoL), follow-up care, and interventions to address their supportive care needs.
methodsThis review was prepared following PRISMA guidelines. Embase, MEDLINE, CINAHL, and Web of Science were searched from January 2020 to February 2025. Primary studies in English that specifically commented on the impact of COVID-19 on the above outcomes were included.
resultsOf the 40 studies included in this review, the most common designs were cross-sectional (n = 14), prospective cohort (n = 10), and qualitative (n = 7), with four randomized controlled trials. Thirty-five studies examined the impact of the COVID-19 pandemic on the quality of life (QoL) of breast cancer survivors (BCS). Twenty studies reported worsened psychological well-being, with increased stress, anxiety, depression, and loneliness. Stressors included fear of COVID-19 exposure during in-person care and concern over service disruptions. Fifteen studies described interruptions to follow-up care, including appointment cancellations and reduced access to surveillance. Eighteen studies noted broader changes to the care model, including virtual interventions and telemedicine, with five evaluating at-home programs and two reporting positive experiences with phone-based follow-up. Five studies addressed concerns about cancer recurrence, with no observed increases but heightened fear. Notably, three studies published after 2023 reported longer-term impacts, such as persistent anxiety, reduced healthcare access, and declines in functional well-being.
conclusionCOVID-19 has negatively impacted the QoL and the care delivery of BCS. Virtual follow-up and interventions were well-received by BCS, and may be recommended as an alternative to in-person care.
Indexed as
Identifiers
42850372What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.